Spatially resolved T cell receptor tracking reveals γδT cell localization to tumor-rich regions in high-risk neuroblastoma: A Report from the Children’s Oncology Group
medRxiv · 2026-06-12
Results of a phase II trial of nivolumab and ipilimumab in children and young adults with relapsed or refractory INI1-deficient cancers.
Journal of Clinical Oncology · 2026-05-27
A First-in-Pediatric Study of ALRN-6924, a Novel Stapled-Peptide Dual MDM2/MDMX Inhibitor, for Children with Advanced Hematologic and Solid Malignancies
Clinical Cancer Research · 2026-05-26
Contemporary Ototoxicity Among Patients With High-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL1531
JCO oncology advances. · 2026-04-01
Collecting Social Determinants of Health in a Children’s Oncology Group Trial for High-Risk Neuroblastoma
JAMA Network Open · 2026-03-02 · 1 citations
Data from A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children’s Oncology Group
2026-01-06
Appendix1 from A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children’s Oncology Group
2026-01-06
Supplementary Material1 from A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children’s Oncology Group
2026-01-06
Assessment of Oral Anticancer Medicines in Pediatric Patients before the Research to Accelerate Cures and Equity (RACE) Act, 2007-2021
The Journal of Pediatrics · 2025-12-12
Presenting Features and Causes of Diagnostic Delays: A Report From the NUT Carcinoma Registry
JCO Precision Oncology · 2025-12-01
A Phase 1 Trial of Fimepinostat in Children and Adolescents With Relapsed and Refractory Solid and <scp>CNS</scp> Tumors
Cancer Medicine · 2025-11-27 · 4 citations
Factors Associated With Primary Site Local Therapy in Patients With Nonmetastatic Ewing Sarcoma Treated With Interval-Compressed Chemotherapy: A Report From the Children’s Oncology Group
International Journal of Radiation Oncology*Biology*Physics · 2025-11-22 · 1 citations
Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancer
European Journal of Cancer · 2025-11-06 · 4 citations
Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group
Journal of Clinical Oncology · 2025-11-03 · 4 citations
Induction Regimens in High‐Risk Neuroblastoma: Systematic Review of Response Rates and Toxicities
Cancer Medicine · 2025-11-01
A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children’s Oncology Group
Clinical Cancer Research · 2025-10-29
Abstract B001: Phase 1/2 trial to evaluate the safety and efficacy of PEEL-224 in combination with vincristine and temozolomide in adolescents and young adults with relapsed or refractory sarcomas
Molecular Cancer Therapeutics · 2025-10-22
Immunogenicity of single-chain antibodies: germlining of a VHH lowers T-cell activation from epitopes in FR2 and CDR regions
mAbs · 2025-10-12 · 2 citations
Abstract IA002: Challenges in accessing innovation for children with cancer
Cancer Research · 2025-09-25
Abstract A003: The clinical impact of targeted next-generation sequencing for advanced pediatric and AYA sarcoma patients in the iCat2/GAIN Consortium Study
Cancer Research · 2025-09-25